October 2021, Episode 103: Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention?